Cargando…
p53–GSDME Elevation: A Path for CDK7 Inhibition to Suppress Breast Cancer Cell Survival
Higher cyclin-dependent kinase (CDK7) expression is a character of breast cancer and indicates poor prognosis. Inhibiting CDK7 exhibited effective cancer cell suppression which implies the potential of CDK7 inhibition to be a method for anti-cancer treatment. Our study aimed to explore a novel mecha...
Autores principales: | Wang, Yueyuan, Peng, Jingyu, Mi, Xuguang, Yang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417410/ https://www.ncbi.nlm.nih.gov/pubmed/34490348 http://dx.doi.org/10.3389/fmolb.2021.697457 |
Ejemplares similares
-
Elevation of effective p53 expression sensitizes wild-type p53 breast cancer cells to CDK7 inhibitor THZ1
por: Wang, Yueyuan, et al.
Publicado: (2022) -
Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53
por: Marques, Mayra A., et al.
Publicado: (2022) -
Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
por: Grinkevich, Vera V., et al.
Publicado: (2022) -
MiR-490-3p Silences CDK1 and Inhibits the Proliferation of Colon Cancer Through an LLPS-Dependent miRISC System
por: Qin, Da, et al.
Publicado: (2021) -
Targeting Mutated p53 Dependency in Triple-Negative Breast Cancer Cells Through CDK7 Inhibition
por: Peng, Jingyu, et al.
Publicado: (2021)